§ Funding Round
$78M Series A
$78M Series A
| Investor | Firm Type | Partner |
|---|---|---|
AbingworthLEAD | Organization | — |
| Organization | — | |
F-Prime CapitalLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
U.S. Renal Care | — | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$775M
Top Valuation
-
R1 Therapeutics raised $775M in a Series A round.
The round was announced on 03/17/26.
The round was led by Abingworth, davita venture group, F-Prime Capital.
